|Day Low/High||2.36 / 2.54|
|52 Wk Low/High||1.49 / 19.21|
Esperion Therapeutics, Agenus Inc. and Baudax Bio could see coming events trigger positive reactions in their shares.
I've previously discussed why these six stocks are my top picks for 2020. I will periodically provide updates and discuss my strategy for trading them.
The higher this market goes the more that many market players wonder how much longer it can last.
Recro Pharma Inc., which makes drugs such as Ritalin LA for Novartis, looks healthy going into 2020.
Some of the best opportunities are in lesser-known niche markets such as medical devices and services.
The selling appears a healthy digestion and we've likely yet to see the indexes reach their highs for the year, but traders should still tread carefully.
Small-cap earnings season is just starting, which is good for stock pickers.
When trading in front of the Fed the focus must be much more defensive than offensive.
We all want a bargain -- meaning we pay less than the highest price -- but that thinking doesn't work with stocks.
The momentum in the broader market is not that strong and the rotational issue continues.
China trade issue is no longer dominating the action.
Flat markets tend to produce favorable technical setups, but this one may put us to sleep while we wait for further developments.
These buyers are most likely to be flippers and they will exit fast and kill the bounce tries.
I'm optimistic that we will see some better stock picking action if the breakout holds and momentum continues.
Knowing when to continue to fish or cut bait is something that develops over time in this space.
While today's action isn't attractive, we were ripe for a little profit-taking.